Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Agilent Technologies announced it has acquired Oxfordshire, U.K.-based Cobalt Light Systems, a provider of highly differentiated Raman spectroscopic instruments for the pharmaceutical industry, applied markets and public safety.
read more
Following cGMP audit of QuVa Pharma's Sugar Land and Temple, Texas facilities, the California Board of Pharmacy has issued Outsource Facility licenses to both QuVa locations.
read more
Spheryx announced the NIH has awarded the company a Phase II SBIR grant to support the modification of their proprietary Total Holographic Characterization technology.
read more
Evotec AG has been awarded a grant for a period of two years from IFB Hamburg to identify and develop therapeutic antibodies directed against novel immune-checkpoints on T-cells to improve future cancer treatments.
read more
ViraCyte has been awarded $3.75M from National Institutes of Health and the FDA to advance its T cell immunotherapies.
read more
Konica Minolta and Ambry Genetics announced the signing of a definitive agreement for a subsidiary of Konica Minolta to acquire Ambry.
read more
Lonza announced it has completed the acquisition of Capsugel from KKR for $5.5 billion in cash, including refinancing of existing Capsugel debt of approximately $2 billion.
read more
Trovagene has formally engaged PRA Health Sciences to conduct Trovagene's Phase 1b/2 clinical trial of PCM-075, a polo-like kinase 1 inhibitor, in patients with AML.
read more
After the sale of its Chemical Development Division to Olon S.p.A., Ricerca Biosciences is being renamed Concord Biosciences.
read more
INC Research announced the launch of Psychiatry Catalyst Site Network as part of its Catalyst program introduced in 2016 to collaborate with clinical research sites worldwide.
read more
Trovagene has executed a supplier agreement with NerPharMa, to manufacture drug product for PCM-075.
read more
ChargePoint Technology has invested in new manufacturing machinery at its UK facility to meet increased demand for larger diameter valves for use in large scale drug manufacturing that requires containment.
read more
Sun Pharma and Samsung BioLogics announced a strategic long-term manufacturing agreement for Tildrakizumab.
read more
Charles River Laboratories announced the appointment of Dr. Martin Mackay, Executive Vice President, Alexion Pharmaceuticals to its Board of Directors.
read more
Amring Pharmaceuticals announced it is a recipient of the Supplier Horizon Award from Premier Inc.
read more